RISING PHARMA HOLDINGS, INC. Ramipril Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Ramipril from India and how much does RISING PHARMA HOLDINGS, INC. import?

India exports Ramipril to 389 buyers globally worth $39.7M. RISING PHARMA HOLDINGS, INC. imports $2.0M (1.1% market share) with 130 shipments from UNITED STATES.

Q: What is the average order value for RISING PHARMA HOLDINGS, INC.'s Ramipril imports?

RISING PHARMA HOLDINGS, INC.'s average Ramipril order value is $15.7K per consignment, based on 130 shipments totaling $2.0M.

Q: Who supplies Ramipril to RISING PHARMA HOLDINGS, INC.?

RISING PHARMA HOLDINGS, INC. sources Ramipril from 1 verified supplier: AUROBINDO PHARMA LIMITED ($2.0M, 100.0%). Based on 130 customs records.

Q: How does RISING PHARMA HOLDINGS, INC. compare to other Ramipril importers?

RISING PHARMA HOLDINGS, INC. ranks #18 among 389 Ramipril importers from India with 1.1% market share and 130 shipments.

Q: Who are the top Ramipril importers from India?

Top Ramipril importers: WOCKHARDT UK LIMITED ($6.7M), CRESCENT PHARMA LTD ($5.8M), BROWN AND BURK UK LIMITED ($4.0M), ZENTIVA ITALIA SRL ($3.8M), M/S CRESCENT PHARMA LTD. ($3.1M).

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

RISING PHARMA HOLDINGS, INC. — Ramipril Importer #18 | $2.0M Trade Value | TransData Nexus | TransData Nexus

RISING PHARMA HOLDINGS, INC. — Ramipril Importer Profile

Pharmaceutical Importer · #18 buyer for Ramipril · $2.0M import value · 130 shipments · UNITED STATES · DGFT Verified

RISING PHARMA HOLDINGS, INC. is the #18 importer of Ramipril from India with $2.0M in import value and 130 verified shipments. RISING PHARMA HOLDINGS, INC. holds a 1.1% market share in Ramipril imports based in UNITED STATES. The company sources from 1 verified supplier across 64 formulations shipped to 1 country. Overall, RISING PHARMA HOLDINGS, INC. imports 18 pharmaceutical products worth $87.0M across 11 therapeutic categories.

RISING PHARMA HOLDINGS, INC. — Ramipril Import Profile: Suppliers, Formulations & Sources

RISING PHARMA HOLDINGS, INC. — Ramipril import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Ramipril to RISING PHARMA HOLDINGS, INC.?

Verified from 130 customs shipment records

Supplier	Value	Shipments	% Share
AUROBINDO PHARMA LIMITED	$2.0M	130	100.0%

RISING PHARMA HOLDINGS, INC. sources Ramipril from 1 verified Indian supplier based on 130 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.

Where Does RISING PHARMA HOLDINGS, INC. Import Ramipril To?

Destination countries from 130 verified shipments

Country	Value	Shipments

What Ramipril Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Formulation	Value	Shipments
RAMIPRIL CAPSULES 10 MG(17328X500'S)NOS	$148.1K	3
RAMIPRIL CAPSULES 5.0 MG (11520X100'S)	$116.1K	6
RAMIPRIL CAPSULES 2.5 MG (2688X500'S)	$108.4K	6
RAMIPRIL CAPSULES 2.5 MG (2880X500'S)	$96.8K	5
RAMIPRIL CAPSULES 10 MG (Ramipril capsul	$88.9K	2
RAMIPRIL CAPSULES 2.5 MG (8448X100'S)	$74.5K	6
RAMIPRIL CAPSULES 10 MG (29088X100'S)NOS	$61.1K	3
RAMIPRIL CAPSULES 10 MG (5773X500'S)	$57.3K	3
RAMIPRIL CAPSULES 10 MG (2880X500'S)	$57.1K	2
RAMIPRIL CAPSULES 2.5 MG (6864X100'S)	$50.4K	5

RISING PHARMA HOLDINGS, INC. imports 64 distinct Ramipril formulations from India. The top formulation is RAMIPRIL CAPSULES 10 MG(17328X500'S)NOS with 3 shipments worth $148.1K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: RISING PHARMA HOLDINGS, INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as RISING PHARMA HOLDINGS, INC.'s capped import value divided by total capped export value for Ramipril across all Indian exporters.
5.Verified Records: This page is backed by 130 individual customs records matching RISING PHARMA HOLDINGS, INC. importing Ramipril, covering 64 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 93+ countries, 389+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ramipril

Ramipril

RISING PHARMA HOLDINGS, INC. — Ramipril Importer Profile

RISING PHARMA HOLDINGS, INC. — Ramipril Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Ramipril to RISING PHARMA HOLDINGS, INC.?

Where Does RISING PHARMA HOLDINGS, INC. Import Ramipril To?

What Ramipril Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Regulatory Requirements: Importing Ramipril into United States

Regulatory Authority

Approval Process for Generic Ramipril

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Ramipril from India and How Much Does RISING PHARMA HOLDINGS, INC. Import?

What Is the Average Order Value for RISING PHARMA HOLDINGS, INC.'s Ramipril Imports?

Who Supplies Ramipril to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Other Ramipril Importers?

What Other Cardiovascular Products Does RISING PHARMA HOLDINGS, INC. Import?

About RISING PHARMA HOLDINGS, INC.

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ramipril Import Data for RISING PHARMA HOLDINGS, INC.

RISING PHARMA HOLDINGS, INC. × Ramipril

Company Overview

Top Products by RISING PHARMA HOLDINGS, INC.

Related Analysis

Need Detailed Import Data?

Data Source